Aksenov, M. ., Aksenova, M. ., Carney, J. ., & Butterfield, D. . (1997). Oxidative modification of glutamine synthetase by amyloid beta peptide. Free Radical Research, 27(3), 267-81. https://doi.org/10.3109/10715769709065765

Aksenov, M. ., Aksenova, M. ., Carney, J. ., & Butterfield, D. . (1996). Alpha 1-antichymotrypsin interaction with A beta (1-42) does not inhibit fibril formation but attenuates the peptide toxicity. Neuroscience Letters, 217(2-3), 117-20. Retrieved from https://linkinghub.elsevier.com/retrieve/pii/0304-3940(96)13082-2 (Original work published 1996)

Aksenova, M. ., Aksenov, M. ., Butterfield, D. ., & Carney, J. . (1996). alpha-1-antichymotrypsin interaction with A beta (1-40) inhibits fibril formation but does not affect the peptide toxicity. Neuroscience Letters, 211(1), 45-8. https://doi.org/10.1016/0304-3940(96)12717-8 (Original work published 1996)

Aksenov, M. ., Aksenova, M. ., Butterfield, D. ., Hensley, K. ., Vigo-Pelfrey, C. ., & Carney, J. . (1996). Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation. Journal of Neurochemistry, 66(5), 2050-6. https://doi.org/10.1046/j.1471-4159.1996.66052050.x

Gabbita, S. ., Aksenov, M. ., Lovell, M. ., & Markesbery, W. . (1999). Decrease in peptide methionine sulfoxide reductase in Alzheimer’s disease brain. Journal of Neurochemistry, 73(4), 1660-6. https://doi.org/10.1046/j.1471-4159.1999.0731660.x